Metal ion interaction with cosubstrate in self-splicing of group I introns
Metal ion interaction with cosubstrate in self-splicing of group I introns
A.-S.
Sjögren
,
E.
Pettersson
1
,
B.-M.
Sjöberg
and
R.
Strömberg
1,2,
*
Department of Molecular Biology and
1
Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, S-10691
Stockholm
,
Sweden
and
2
Laboratory of Organic and Bioorganic Chemistry, Department of Medical
Biochemistry and Biophysics, Karolinska Institutet, S-17177
Stockholm
,
Sweden
Received August 28, 1996;
Revised and Accepted December 4, 1996
ABSTRACT
The catalytic mechanism for self-splicing of the group I intron in the pre-mRNA from the
nrdB
gene in bacteriophage T4 has been investigated using 2
'
-amino- 2
'
-deoxyguanosine or guanosine as cosubstrates in the presence of Mg
2+
, Mn
2+
2+. The results show that a divalent metal ion interacts with the cosubstrate and thereby influences the efficiency of catalysis in the first step of splicing. This suggests the existence of a metal ion that catalyses the nucleophilic attack of the cosubstrate. Of particular significance is that the transesterification reactions of the first step of splicing with 2'-amino-2'-deoxyguanosine as cosubstrate are more efficient in mixtures containing
either Mn
2+
or
Zn
2+
together with Mg
2+
than with only magnesium ions present. The experiments in metal ion mixtures
show that two (or more) metal ions are crucial for the self-splicing of group I introns and suggest the possibility that more than one
of these have a direct catalytic role. A working model for a two-metal-ion mechanism in the transesterification steps is suggested.
INTRODUCTION
Self-splicing of group I introns from precursors (pre-mRNAs) to messenger RNAs requires two consecutive
transesterifications of internucleosidic phosphodiester linkages. The first
step being cleavage of the exon 1-intron junction by an exogenous guanosine cosubstrate and the second
being ligation of the exons (
1
,
2
). The pre-mRNA from the
nrdB
gene in bacteriophage T4 contains a self-splicing group I intron (Scheme 1a) (
3
,
4
). Our present work is focused on the first step of splicing, i.e., where the
external guanosine cosubstrate, with the 3'-hydroxyl as the nucleophilic function, attacks the internucleosidic
phosphodiester linkage at the exon1-intron junction and becomes covalently
attached to the 5'-end of the intron (Scheme 1b). It is well known that divalent metal
ions are necessary for the function of group I introns (
1
,
2
,
5
). More recently, photo-crosslinking experiments in the L-21 ScaI system have shown that magnesium ion coordination near the
splice site is crucial for folding into an active ribozyme (
6
). In addition, phosphorothioate substitution interference experiments have
identified several magnesium ion coordination sites close to where the
cosubstrate binds (
7
).
Piccirilli
et al.
(
8
)
have provided experimental support for the existence of a magnesium ion that
promotes the reaction by coordinating to, and facilitating leaving of, the
oxyanion of exon 1 (oxygen
c
in Scheme 1b). In an analogous model system (trimethoxyphosphorane dianion)
calculations on the influence of metal ions suggest that the phosphorane
intermediate would break down spontaneously in the presence of magnesium ions (
9
). Mechanisms involving two catalytic metal ions have been discussed (
1
,
2
,
5
,
8
-
11
). Steitz and Steitz suggested that splicing by group I introns utilises a two-metal-ion mechanism which may be general for many enzyme-catalysed phosphoryl transfers (
10
). Molecular dynamics simulation also shows the plausibility of a mechanistic
model involving two catalytic magnesium ions (
11
). Furthermore, Streicher
et al.
(
12
) have reported indications of two defined metal ion binding pockets close to
the cleavage site in the phage T4
td
intron and suggested that these may be sites for catalytic ions. However, until
now no experimental support has been reported for a metal ion that would be
involved in promoting nucleophilic attack by the guanosine cosubstrate.
MATERIALS AND METHODS
Materials
Deoxynucleotides, nucleotides, Nick-columns (G-50), RNA-guard and T7 RNA polymerase were from Pharmacia. Guanosine,
spermidine, diethyl pyrocarbonate (DEPC) were from Sigma. Labelled [
35
S]UTP[alpha]S was purchased from Amersham,
Hpa
I from USB and DNaseI from Boehringer Mannheim. All solutions were DEPC-treated. 2'-Amino-2'-deoxyguanosine was synthesized using
published procedures (
17
,
18
) and purified as reported (
16
).
Methods
Preparation of RNA
. The shortened version of the self-splicing pre-mRNA from the phage T4
nrdB
-gene used in the kinetic experiments is a linearised plasmid, pBS5[Delta]1-650 (Sjögren, A-S, Strömberg, R. and Sjöberg, B-M., manuscript in preparation).
It contains the T7 RNA polymerase promoter in front of 9 nucleotides (nt) of
LacZ RNA sequence, 13 (intron proximal) nt of exon 1, the 598 nt intron and the
500 nt exon 2.
In vitro
transcription of pBS5[Delta]1-650, linearized with
Hpa
I, produces a transcript of 820 nt; 22 nt of exon 1, 598 nt of intron and 200 nt of exon 2. Several (up to 10) transcription mixtures of 40 [mu]l in 40 mM Hepes-KOH, pH 7.0, 1 mM each of ATP, CTP, GTP, 0.5 mM UTP, 1 [mu]Ci [
35
S]UTP[alpha]S (400 Ci/mmol), 2 mM MgCl
2
, 0.4 mM spermidine, 30 U RNA guard, 0.01 M dithiothreitol, 1 [mu]g of linear plasmid and 120 U T7 RNA polymerase were incubated at 37oC for 50 min. The reaction was stopped by phenol:chloroform:isoamyl
alcohol (25:24:1) treatment. The labelled transcript was DNaseI treated,
extracted by phenol:chloroform:isoamyl alcohol (25:24:1), and desalted on Sephadex G-50 (10 mM Tris-HCl, pH 7.5 and 1 mM EDTA) to remove excess nucleotides. No detectable
splicing of the pre-mRNA transcript occurred during transcription and purification. The
purified pre-mRNA was precipitated in 4 M ammonium acetate and ethanol, dissolved in
water and stored at -20oC.
Splicing conditions
. Immediately prior to splicing reactions nanomolar concentrations of pre-mRNA were denatured at 95oC for 30 s, transferred to 4oC and left for 1.5 min and then brought to 32oC after which the folding buffer was added. The pre-mRNA was allowed to fold at 32oC for 4 min in 5/4 concentration of the splicing
buffer. Splicing reactions were performed in 40 mM Pipes-KOH buffer, pH 7.2, 60 mM KCl and 4 mM for Mg
2+
or 0.9 mM for Mn
2+
. Reactions were stopped by adding an equal volume of 10 M urea, 50 mM EDTA,
0.1% bromophenolblue and 0.25% xylenecyanol.
Splicing reactions in the presence of metal ion mixtures contained either 4.0 mM
of total divalent metal ion concentration (Mg
2+
/Mn
2+
ratios as given in Fig.
2
) or 4 mM Mg
2+
plus Zn
2+
or Mn
2+
(as indicated in Table
2
). Folding of the RNA in the presence of only Mg
2+
followed by addition of Mn
2+
at the start of the splicing reaction gave similar cooperative effects as
folding in mixtures of the metal ions.
Nucleoside concentrations were determined spectrophotometrically at pH 1.0.
Extinction coefficients used were 12 200 M
-1
cm
-1
(256 nm) for guanosine and 12 500 M
-1
cm
-1
(255 nm) for 2'-amino-2'-deoxyguanosine (
19
).
Kinetic evaluation.
Splicing products and intermediates were separated by electrophoresis on 3.4%
polyacrylamide/8 M urea gels and quantified using the PhosphorImager system
(Molecular Dynamics). The observed first order rate constants (
k
obs)
were determined by fitting a linear equation to the plot of the natural
logarithm of the remaining precursor fraction [ln F(pre-mRNA)] versus time of incubation. The reactions were followed for up to
80% conversion and total RNA was calculated as the sum of remaining `pre-mRNA' (221 uridine residues, Us), weighted intron (156 Us) and weighted AG- or G-intron-exon 2 (212 Us).
The kinetic analysis is based on the following observations. Since a difference
in rate for the two cosubstrates is observed, a step preceding those involving
the cosubstrate can not be rate-limiting. The disappearance of the pre-mRNA exhibits good first order kinetics throughout the experiments
(over two half-lives), which suggests that
k-
1 must be substantially larger than
k
2
and, since substrate saturation is obtained, we must have a real pre-equilibrium followed by a slower step. The concentration of the intermediate G-intron-exon 2 (or AG-intron-exon 2) is built up to later disappear during the
course of the reaction, which suggests not too different
k
2
and
k
3
values (curve fitting using equations for consecutive reaction also suggest that
k
3
is not dependent on substrate concentration). We quantify both this
intermediate and the G-intron and treat the two splicing steps as simple consecutive reactions
[i.e. first order kinetics of the disappearance of pre-mRNA to products (both G-intron-exon 2 and G-intron)]. The initial rate of formation of the intermediate G-intron-exon 2 appears to be identical to the rate of
disappearance of the pre-mRNA, which is constant throughout the two half-lives through which we follow the reaction (while the rate of
formation of the intermediate levels off). This shows that
k-
2 is small enough not to cause any significant equilibration back to pre-mRNA. These observations lead to the conclusion of limits to the ratios of
rate constants that in practice means that an obtained
k
cat
value in essence is equal to
k
2
. That we are monitoring the first catalytic step is also supported by the
observations that log (
k
cat)
and log (
k
cat
/
K
M
) are linearly dependent on pH (Sjögren, A-S, Strömberg, R. and Sjöberg, B-M., manuscript in preparation) which is consistent with increased deprotonation of the 3'-hydroxyl at higher pH (as was also
found in the L-21 Sca1 system by Herschlag and Khosla) (
20
).
RESULTS
ACKNOWLEDGEMENTS
We thank Prof. Tomas R. Cech and Dr Dan Herschlag for comments and the Swedish
Natural Science Research Council and Pharmacia Research Funds for financial
support.
REFERENCES
1 Cech, T. R., Herschlag, D., Piccirilli, J. A. and Pyle, A. M. (1992) J. Biol. Chem., 267,17479-17482.
2 Gesteland, R.F. and Atkins, J.F. (1993) The RNA World. Cold Spring Harbor Laboratory Press, New York.
3 Gott, J. M., Shub, D. A. and Belfort, M. (1986) Cell, 47,81-87.
4 Sjöberg, B. M., Hahne, S., Mathews, C. Z., Mathews, C. K., Rand, K. N. and Gait, M. J. (1986) EMBO J., 5,2031-2036.
6 Wang, J. F. and Cech, T. R. (1994) J. Am. Chem. Soc., 116,4178-4182.
7 Christian, E. L. and Yarus, M. (1993) Biochemistry, 32,4475-4480.
8 Piccirilli, J. A., Vyle, J. S., Caruthers, M. H. and Cech, T. R. (1993) Nature, 361,85-88.
9 Uchimaru, T., Uebayasi, M., Tanabe, K. and Taira, K. (1993) FASEB J., 7,137-142.MEDLINE Abstract
10 Steitz, T.A. and Steitz, J.A. (1993) Proc. Natl. Acad. Sci. USA, 90, 6498-6502.MEDLINE Abstract
11 Setlik, R. F., Gardunojuarez, R., Manchester, J. I., Shibata, M., Ornstein, R. L. and Rein, R. (1993) J. Biomol. Struct. Dyn., 10,945-972.
12 Streicher, B., Westhof, E. and Schroeder, R. (1996) EMBO J., 15, 2556-2564.MEDLINE Abstract
13 Bass, B. L. and Cech, T. R. (1984) Nature, 308,820-826.
14 Bass, B. L. and Cech, T. R. (1986) Biochemistry, 25,4473-4477.
15 Moran, S., Kierzek, R. and Turner, D. H. (1993) Biochemistry, 32,5247-5256.MEDLINE Abstract
16 Strömberg, R., Hahne, S., Sjögren, A.-S. and Sjöberg, B.-M. (1992) Biochem. Biophys. Res. Commun., 183,842-848.
17 Hobbs, J.B. and Eckstein, F. (1977) J. Org. Chem., 42, 714-719.MEDLINE Abstract
18 Imazawa, M. and Eckstein, F. (1979) J. Org. Chem., 44, 2039-2041.
19 Kuusela, S. and Lönnberg, H. (1994) J. Chem. Soc. Perkin. Trans. 2, 2301-2306.
20 Herschlag, D. and Khosla, M. (1994) Biochemistry, 33,5291-5297.MEDLINE Abstract
21 Kuusela, S. and Lönnberg, H. (1993) J. Phys. Org. Chem., 6, 347-356.
22 Sille'n, L.G. and Martell, A.E. (1964) Stability Constants of Metal-Ligand Complexes, Special publication 17. The Chemical Society, London.
23 Sille'n, L.G. and Martell, A.E. (1968) Stability Constants, Supplement No 1, Special Publication 25. The Chemical Society, London.
24 Williams, N. H. and Chin, J. (1996) J. Chem. Soc. Chem. Comm., 131-132.
25 Hendry, P. and Sargeson, A. M. (1990) Inorg. Chem., 29, 92-97.
26 McSwiggen, J. A. and Cech, T. R. (1989) Science, 244,679-683.
27 Rajagopal, J., Doudna, J. A. and Szostak, J. W. (1989) Science, 244,692-694.MEDLINE Abstract
28 Suh, E. and Waring, R. B. (1992) Nucleic Acids Res., 20,6303-6309.MEDLINE Abstract
29 Herschlag, D., Piccirilli, J. A. and Cech, T. R. (1991) Biochemistry,30,4844-4854.MEDLINE Abstract
30 Shub, D. A., Gott, J. M., Xu, M-Q., Lang, B. F., Michel, F., Tomaschewski, J., Pedersen-Lane, J. and Belfort, M. (1988) Proc. Natl. Acad. Sci. USA, 85, 1151-1155.